Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zuzana Walek"'
Publikováno v:
Cells, Vol 12, Iss 23, p 2748 (2023)
Multiple myeloma (MM) has witnessed improved patient outcomes through advancements in therapeutic approaches. Notably, allogeneic stem cell transplantation, proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies have contributed to
Externí odkaz:
https://doaj.org/article/e584c3d8d159453a8a6416b8c453e9d5
Autor:
Sandra Charvátová, Benjamin Motais, Justyna Czapla, Tomasz Cichoń, Ryszard Smolarczyk, Zuzana Walek, Sebastian Giebel, Roman Hájek, Juli R. Bagó
Publikováno v:
Cells, Vol 12, Iss 3, p 448 (2023)
Myeloma bone disease (MBD) is one of the major complications in multiple myeloma (MM)—the second most frequent hematologic malignancy. It is characterized by the formation of bone lesions due to the local action of proliferating MM cells, and to da
Externí odkaz:
https://doaj.org/article/4c28c9e36fa64929a560eb1aba01bcc8
Autor:
Benjamin Motais, Sandra Charvátová, Zuzana Walek, Matouš Hrdinka, Ryszard Smolarczyk, Tomasz Cichoń, Justyna Czapla, Sebastian Giebel, Michal Šimíček, Tomáš Jelínek, Tereza Ševčíková, Jiří Sobotka, Zdeněk Kořístek, Roman Hájek, Juli R. Bagó
Publikováno v:
Cells, Vol 10, Iss 5, p 967 (2021)
Cellular immunotherapy is becoming a new pillar in cancer treatment after recent striking results in different clinical trials with chimeric antigen receptor T cells. However, this innovative therapy is not exempt from challenges such as off-tumor to
Externí odkaz:
https://doaj.org/article/f6a2e2b59cd641978a04a955a739f7f8